Provided By PR Newswire
Last update: Nov 24, 2025
Sanofi and Symphony Health teams conducted the study demonstrating how Dario's digital, diabetes intervention platform reduces real-world healthcare burden and cost compared to usual care
Read more at prnewswire.comNASDAQ:DRIO (12/3/2025, 4:44:33 PM)
11.85
-0.04 (-0.34%)
Find more stocks in the Stock Screener


